New review shows potential of Vitamin B3 for preventing melanoma

NewsGuard 100/100 Score

A new review highlights the potential of nicotinamide (Vitamin B3) for preventing melanoma in high-risk individuals.

Nicotinamide can help reduce or reverse DNA damage, inflammation, and immunosuppression caused by ultraviolet radiation.

The cost of nicotinatimide is approximately $10 per month if taken at 1g per day as recommended. Randomized placebo controlled trials are now warranted to determine its efficacy and safety for melanoma prevention.

"Nicotinamide has been shown in a clinical trial—called ONTRAC—to reduce the incidence of non-melanoma skin cancer in high-risk individuals and it would be worthwhile to determine whether it would also be useful for high-risk melanoma patients," said Dr. Gary Halliday, senior author of the Photodermatology, Photoimmunology & Photomedicine review.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
UCLA and UAMS teams secure $3.2 million NIH grant for melanoma research